MCID: PST032
MIFTS: 13

Posterior Urethra Cancer

Categories: Cancer diseases

Aliases & Classifications for Posterior Urethra Cancer

MalaCards integrated aliases for Posterior Urethra Cancer:

Name: Posterior Urethra Cancer 12
Posterior Urethral Malignant Tumor 12
Posterior Urethral Cancer 69

Classifications:



External Ids:

Disease Ontology 12 DOID:7488
NCIt 47 C7640
UMLS 69 C0279931

Summaries for Posterior Urethra Cancer

MalaCards based summary : Posterior Urethra Cancer, is also known as posterior urethral malignant tumor. The drugs Carboplatin and Cisplatin have been mentioned in the context of this disorder. Affiliated tissues include prostate, liver and kidney.

Related Diseases for Posterior Urethra Cancer

Diseases in the Anterior Urethra Cancer family:

Posterior Urethra Cancer

Symptoms & Phenotypes for Posterior Urethra Cancer

Drugs & Therapeutics for Posterior Urethra Cancer

Drugs for Posterior Urethra Cancer (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 62)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Carboplatin Approved Phase 3,Phase 2 41575-94-4 10339178 498142 38904
2
Cisplatin Approved Phase 3,Phase 2 15663-27-1 84093 441203 2767
3
Gemcitabine Approved Phase 2, Phase 3 95058-81-4 60750
4
Doxorubicin Approved, Investigational Phase 3,Phase 2 23214-92-8 31703
5
Methotrexate Approved Phase 3,Phase 2 1959-05-2, 59-05-2 126941
6
Paclitaxel Approved, Vet_approved Phase 3,Phase 2 33069-62-4 36314
7
Vinblastine Approved Phase 3,Phase 2 865-21-4 13342 241903
8
Folic Acid Approved, Nutraceutical, Vet_approved Phase 3,Phase 2 59-30-3 6037
9
leucovorin Approved, Nutraceutical Phase 3,Phase 2 58-05-9 143 6006
10
Doxil Approved June 1999 Phase 3,Phase 2 31703
11 Antimetabolites Phase 3,Phase 2
12 Antimetabolites, Antineoplastic Phase 3,Phase 2
13 Immunosuppressive Agents Phase 3,Phase 2,Phase 1
14 Anti-Infective Agents Phase 2, Phase 3,Phase 1
15 Antiviral Agents Phase 2, Phase 3,Phase 1
16 Albumin-Bound Paclitaxel Phase 3,Phase 2
17 Anti-Bacterial Agents Phase 3,Phase 2,Phase 1
18 Antibiotics, Antitubercular Phase 3,Phase 2
19 Antimitotic Agents Phase 3,Phase 2,Phase 1
20 Antineoplastic Agents, Phytogenic Phase 3,Phase 2
21 Antirheumatic Agents Phase 3,Phase 2
22 Dermatologic Agents Phase 3,Phase 2
23 Folic Acid Antagonists Phase 3,Phase 2
24 Nucleic Acid Synthesis Inhibitors Phase 3,Phase 2
25 Topoisomerase Inhibitors Phase 3,Phase 2
26 Vitamin B Complex Phase 3,Phase 2
27 Folate Nutraceutical Phase 3,Phase 2
28 Vitamin B9 Nutraceutical Phase 3,Phase 2
29
Fluorouracil Approved Phase 2 51-21-8 3385
30
Sunitinib Approved, Investigational Phase 2 341031-54-7, 557795-19-4 5329102
31
Ifosfamide Approved Phase 2 3778-73-2 3690
32
Lenograstim Approved Phase 2 135968-09-1
33
Mechlorethamine Approved Phase 2 51-75-2 4033
34
Pemetrexed Approved, Investigational Phase 2 150399-23-8, 137281-23-3 446556 60843
35
Irinotecan Approved, Investigational Phase 2 97682-44-5, 100286-90-6 60838
36
Gefitinib Approved, Investigational Phase 2 184475-35-2 123631
37
Levoleucovorin Approved Phase 2 68538-85-2
38
Romidepsin Approved, Investigational Phase 2 128517-07-7 5352062
39
Camptothecin Experimental Phase 2 7689-03-4
40
Docetaxel Approved May 1996, Investigational Phase 2,Phase 1 114977-28-5 148124 9877265
41
Iodine Investigational Phase 2 7553-56-2 807
42 Angiogenesis Inhibitors Phase 2,Phase 1
43 Angiogenesis Modulating Agents Phase 2,Phase 1
44 Alkylating Agents Phase 2
45 Isophosphamide mustard Phase 2
46 topoisomerase I inhibitors Phase 2
47 Protein Kinase Inhibitors Phase 2
48 Rubitecan Phase 2
49 Anesthetics Phase 2,Phase 1
50 Anti-Infective Agents, Local Phase 2

Interventional clinical trials:

(show all 32)

id Name Status NCT ID Phase Drugs
1 Prospective Randomized Comparison of Transurethral Resection by Mean of White Light and Narrow Band Imaging Unknown status NCT01004211 Phase 3
2 Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium Completed NCT00003376 Phase 3 carboplatin;cisplatin;doxorubicin hydrochloride;methotrexate;paclitaxel;vinblastine
3 Combination Chemotherapy in Treating Patients With Transitional Cell Cancer of the Urothelium Completed NCT00014274 Phase 2, Phase 3 carboplatin;gemcitabine hydrochloride;methotrexate;vinblastine sulfate
4 Surgery Plus Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Urinary Tract Unknown status NCT00006111 Phase 2 cisplatin;fluorouracil
5 Gemcitabine Hydrochloride, Cisplatin, and Sunitinib Malate as First-Line Therapy in Treating Patients With Locally Advanced And/or Metastatic Transitional Cell Carcinoma of the Urothelium Unknown status NCT01089088 Phase 2 cisplatin;gemcitabine hydrochloride;sunitinib malate
6 Carboplatin and Gemcitabine Hydrochloride With or Without Vandetanib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urinary Tract Cancer Unknown status NCT01191892 Phase 2 carboplatin;gemcitabine hydrochloride;vandetanib;Placebo
7 Neoadjuvant Ifosfamide, Doxorubicin, Gemcitabine, and Cisplatin in Treating Patients Who Are Undergoing Radical Cystectomy for Locally Advanced Carcinoma (Cancer) of the Urothelium Completed NCT00080795 Phase 2 cisplatin;doxorubicin hydrochloride;gemcitabine hydrochloride;ifosfamide
8 S0219, Combination Chemotherapy Followed By Observation or Surgery in Patients With Stage II or Stage III Cancer of the Urothelium Completed NCT00045630 Phase 2 carboplatin;gemcitabine;paclitaxel
9 Sunitinib in Treating Patients With Progressive Metastatic Transitional Cell Cancer of the Urothelium Completed NCT00397488 Phase 2 sunitinib malate
10 SCH 66336 Plus Gemcitabine in Treating Patients With Advanced Cancer of the Urinary Tract Completed NCT00006351 Phase 2 gemcitabine hydrochloride;lonafarnib
11 Pemetrexed Disodium and Gemcitabine in Treating Patients With Advanced Cancer of the Urothelium Completed NCT00053209 Phase 2 gemcitabine hydrochloride;pemetrexed disodium
12 S0306, Irinotecan in Treating Patients With Recurrent or Refractory Advanced Transitional Cell Cancer of the Urothelium Previously Treated With Chemotherapy Completed NCT00066612 Phase 2 irinotecan hydrochloride
13 S0031, ZD 1839 in Treating Patients With Advanced Cancer of the Urinary Tract Completed NCT00014144 Phase 2 gefitinib
14 Nitrocamptothecin in Treating Patients With Metastatic Cancer of the Urinary Tract Completed NCT00006026 Phase 2 rubitecan
15 Docetaxel and Gemcitabine in Treating Patients With Progressive Regional or Metastatic Bladder Cancer Completed NCT00004223 Phase 2 docetaxel;gemcitabine hydrochloride
16 Fluorouracil, Leucovorin, Gemcitabine, and Cisplatin in Treating Patients With Metastatic or Unresectable Adenocarcinoma of the Urothelium or Urachal Remnant Active, not recruiting NCT00082706 Phase 2 5-Fluorouracil (5-FU);Leucovorin;Cisplatin;Gemcitabine
17 HDR Brachytherapy vs. LDR Brachytherapy Monotherapy in Localized Prostate Cancer Active, not recruiting NCT02628041 Phase 2
18 Atezolizumab With or Without Eribulin Mesylate in Treating Patients With Recurrent Locally Advanced or Metastatic Urothelial Cancer Not yet recruiting NCT03237780 Phase 2 Atezolizumab;Eribulin Mesylate
19 S0028, Gemcitabine and Paclitaxel in Treating Patients With Advanced or Recurrent Cancer of the Urinary Tract Terminated NCT00022633 Phase 2 gemcitabine hydrochloride;paclitaxel
20 S0400, FR901228 in Treating Patients With Advanced Cancer of the Urothelium Terminated NCT00087295 Phase 2 Depsipeptide
21 Gemcitabine Hydrochloride and Cisplatin or High-Dose Methotrexate, Vinblastine, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Urothelial Cancer Withdrawn NCT01639521 Phase 2 cisplatin;gemcitabine hydrochloride;methotrexate;vinblastine;doxorubicin hydrochloride
22 Dorsal Penile Block for Post-Robotic Prostatectomy Foley Discomfort Withdrawn NCT01565512 Phase 1, Phase 2 Bupivacaine;Saline
23 Short-Term Low-Dose Interferon Alfa in Treating Patients With Cancer of the Urothelium Completed NCT00082719 Phase 1
24 Thalidomide and Docetaxel in Treating Patients With Advanced Cancer Completed NCT00049296 Phase 1 docetaxel;thalidomide
25 MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma Completed NCT00020579 Phase 1 entinostat
26 Biomarkers in Patients With Kidney Cancer or Cancer of the Urothelium and in Healthy Participants Completed NCT00900276
27 Early Intervention vs. Standard Palliative Care in Improving End-of-Life Care in Advanced Cancer Patients Completed NCT00253383
28 Transcorporal Versus Standard Artificial Urinary Sphincter Placement Recruiting NCT02591381
29 Care of the Urothelial Cancer Patient and Prospective Procurement of Urothelial Cancer Tissue Recruiting NCT02379429
30 Focal ExAblate MR-Guided Focused Ultrasound Treatment for Management of Organ-Confined Intermediate Risk Prostate Cancer Recruiting NCT02968784
31 Modifications to Radical Prostatectomy: Feasibility Study Active, not recruiting NCT00928850
32 Initial Experience in Brazilian Single Center With High Intensity Focalized Ultrasound (HIFU) Prostate Cancer Therapy: Morbidity, Oncological and Functional Outcomes. Not yet recruiting NCT03255135

Search NIH Clinical Center for Posterior Urethra Cancer

Genetic Tests for Posterior Urethra Cancer

Anatomical Context for Posterior Urethra Cancer

MalaCards organs/tissues related to Posterior Urethra Cancer:

39
Prostate, Liver, Kidney

Publications for Posterior Urethra Cancer

Variations for Posterior Urethra Cancer

Expression for Posterior Urethra Cancer

Search GEO for disease gene expression data for Posterior Urethra Cancer.

Pathways for Posterior Urethra Cancer

GO Terms for Posterior Urethra Cancer

Sources for Posterior Urethra Cancer

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....